<DOC>
	<DOCNO>NCT00336635</DOCNO>
	<brief_summary>The currently available stock smallpox vaccine would insufficient face incident smallpox attack . Thus , new manufacture method smallpox vaccine urgently need previous manufacture method use calf lymph longer acceptable view current standard . Recently , CJ corporation Republic Korea develop cell-culture derive smallpox vaccine ( CJ-50300 ) manufacture infect MRC-5 cell . The aim phase 1 clinical trial ass safety , reactogenicity , immunogenicity CJ-50300 .</brief_summary>
	<brief_title>Safety Immunogenicity CJ-50300</brief_title>
	<detailed_description />
	<mesh_term>Smallpox</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Healthy Korean male female subject 20 28 year age time screen visit . 2 . Willing participate sign informed consent form 3 . In good general health , without clinically skin disease history , physical examination laboratory test result 4 . Hematocrit &gt; 33 % woman ; &gt; 38 % men 5 . White cell count 3,30012,000/mm3 6 . Total lymphocyte count &gt; 800 cells/mm3 1 . Diseases condition cause immunodeficiency ( For example ; HIV AIDS , leukemia , lymphoma , generalized malignancy , agammaglobulinemia , history transplantation , therapy alkylating agent , antimetabolite , radiation , oral parenteral corticosteroid ) . 2 . In close physical contact ( household work ) individual disease condition cause immunodeficiency 3. history present eczema atopic dermatitis 4 . Allergy sensitivity know component vaccine medicine 5 . In close physical contact ( household work ) individual acute chronic skin condition dermatitis , exfoliative dermatitis 6 . Subjects inflammatory ophthalmic disease require steroid therapy 7 . Subjects plan blood donation 8 . Autoimmune disease lupus erythematosus 9 . Subjects work medical institution 10 . Household contact woman pregnant breastfeed 11 . Female Subjects pregnant breastfeed positive result serum pregnancy test urine pregnancy test , use approve contraceptive sterilization , contraceptive ring injectable , combined oral contraceptive pill barrier contraceptive , combine hormonebased therapy , contraceptive cream , contraceptive jelly , diaphragm condom 12 . Subjects household member &lt; 1 year old work child &lt; 1 year old 13 . Subjects know history Cardiac disease three follow risk factor : hyperpiesia , obesity , hyperlipidemia , glucosuria , sclerosis , cerebral arteriosclerosis 14 . Receipt immunoglobulin steroid within 14 day vaccination 15 . Receipt investigational research agent within 120 day vaccination 16 . HBsAg seropositive 17 . HCV antibody seropositive 18 . HIV seropositive 19 . Subjects fever ( oral temperature &gt; 38℃ ) severe nutrition disorder 20 . Blood donation within 12 week advance screen visit 21 . Subject suitable participate study accord invesigator ’ judgement</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>28 Years</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>smallpox , vaccine , immunity</keyword>
</DOC>